Monday = Sanofi Executes Option to develop, manufacture and commercialise a respiratory disease self-assessment application specifically for consumers
Tuesday = FDA Classification for de novo Class II Medical device for respiratory disease diagnosis in paediatrics
Wednesday sp = 0.40
FMD...patience of a rock required
2020 The Year Of RAP, page-1341
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #